Cipla Ltd. Appoints Vice-Chairman and Approves Subsidiary Investments, Amalgamation
Cipla Ltd. announced several key developments following a board meeting held on March 19, 2026. Mr. P R Ramesh, Lead Independent Director, has been designated as Vice-Chairman of the Company, effective April 1, 2026.Additionally, Mr. Robert Stewart, an Independent Director, has expressed his intention not to seek reappointment upon completion of his current term on May 13, 2026.
The board approved an investment of up to USD 100 million in the equity share capital of Cipla (EU) Limited, a wholly-owned subsidiary, to provide financial assistance to InvaGen Pharmaceuticals Inc., another wholly-owned subsidiary of Cipla (EU) Limited. These funds will be used for capital expenditure, working capital requirements, and other corporate purposes.
Furthermore, the board approved a scheme of amalgamation of Inzpera Healthsciences Limited, a wholly-owned subsidiary, with Cipla Ltd. The amalgamation is subject to approvals under the Companies Act, 2013, including approval from the National Company Law Tribunal, Mumbai. Cipla stated that the amalgamation is not expected to have a material impact on the company's financials.
Financial Details of Cipla (EU) Limited
The following table summarizes key financial details for Cipla (EU) Limited:
| Particulars | Details (USD crore) |
|---|---|
| Turnover | 3.76 |
| Profit After Tax | 0.60 |
| FY 2023-24 Turnover | 2.51 |
| FY 2022-23 Turnover | 2.91 |
| FY 2024-25 Turnover | 3.76 |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Last edited by a moderator: